Please login to the form below
Medicxi
This page shows the latest Medicxi news and features for those working in and with pharma, biotech and healthcare.
Novartis and J&J back latest €400m Medicxi biopharma fund
to Medicxi, with European companies growing in stature and offering improved returns on investment for backers. ... to the US, Medicxi’s co-founder Francesco De Rubertis told the Financial Times.
Latest news
-
Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance
The breadth of candidates in Sosei Heptares’ pipeline prompted the company to hive off some neurological programmes into two virtual companies – called Orexia and Inexia - with funding from Medicxi Ventures.
-
Evotec spins off cancer tech into new Breakpoint company
life sciences investor group Medicxi, the venture capital arm of Japanese drugmaker Taiho.
-
Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
Gadeta was founded in 2015 by Professor Jürgen Kuball, Mark de Boer, Utrecht Holdings and venture fund Medicxi, its founding investor.
-
Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding
Two new investors, Medicxi and RA Capital Management, participated in the financing, which will fund the development of T-Guard into phase III registration trials, arranging commercial-scale production and marketing
-
Medicxi aims to plug funding gap for European biotech
Backed by Novartis and Alphabet's Verily unit, Medicxi Ventures has set up a $300m biotech fund that will back European growth-stage biotechs - that it says do not have access ... The European life sciences sector is recognised for its innovation, but
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
Building European biotech firms to rival those of the US
Richard Mason (pictured above) is a veteran of the UK biotech industry, including a spell as CEO of company XO1 set up by venture capital investors Index Ventures (now Medicxi) in
-
European biotech: a new generation of leaders emerges
One key venture capital fund is London-based Medicxi, which raised 400m ($450m) from investors earlier this year for its third biopharma development fund. ... Medicxi III will be also supported by the investment firm’s scientific advisory board, which
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Medicxi appoints former GSK chair Moncef Slaoui
He joins the life science investment firm as a partner. London, UK-based life science investment group Medicxi has appointed former GSK chairman of pharmaceutical R&D, vaccines Dr Moncef Slaoui ... He said: “Having developed a strong relationship with
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
VISFO
A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
